Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News GT Biopharma Inc GTBP

Healthcare Biotechnology Diagnostics & Research
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. Its TriKE platform generates therapeutics designed to harness and enhance the cancer killing abilities of a patient’s own natural... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GTBP)

GT Biopharma Reports Third Quarter 2024 Financial Results

GlobeNewswire 10 days ago

GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GlobeNewswire September 26, 2024

GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024

GlobeNewswire September 24, 2024

GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire August 14, 2024

GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia

GlobeNewswire June 27, 2024

GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire May 21, 2024

GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire May 15, 2024

GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire March 26, 2024

GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split

GlobeNewswire February 1, 2024
View More News ››

Opinion & Analysis (NDAQ:GTBP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:GTBP)

GT Biopharma, Inc. (NASDAQ:GTBP): Advancing Innovative Immun

http://beyondspx.com/2024/08/01/gt-biopharma-inc-nasdaqgtbp-advancing-innovative-immuno-oncology-therapies/
MikeTester - August 2, 2024

What's Going On With GT Biopharma Stock? | Benzinga

News; $GTBP What's Going On With GT Biopharma Stock? | BenzingaGT Biopharma, Inc. (NASDAQ:GTBP) shares are racing higher Monday on...
whytestocks - May 20, 2024

What made GT Biopharma stock more than double on Monday?

News; $GTBP What made GT Biopharma stock more than double on Monday?2024-05-20 10:43:46 ET GT Biopharma Inc (NASDAQ: GTBP) is up a...
whytestocks - May 20, 2024
View more Bullboard ››

Copper Lake Resources Ltd.

Copper Lake Resources Ltd.

Copper Lake Resources Ltd. is a Canadian mineral exploration and development company with interests in two projects both ...
View More »